粉防己碱
顺铂
卵巢癌
细胞毒性
体内
药理学
细胞凋亡
癌症研究
毒性
医学
癌症
化疗
体外
生物
内科学
生物化学
生物技术
作者
Yuxing Zhang,Chao Wang,Haiwei Wang,Kankan Wang,Yanzhi Du,Ji Zhang
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2011-02-19
卷期号:304 (1): 21-32
被引量:62
标识
DOI:10.1016/j.canlet.2011.01.022
摘要
Cisplatin, as a first-line drug in the chemotherapy of ovarian cancer, poses significant problems in its toxicity to normal tissue and drug resistance. Here, we report that Tetrandrine, with potent anti-cancer effect, significantly enhances the cytotoxicity of cisplatin in ovarian cancer. The in vitro assay indicates that Tetrandrine can markedly increase growth suppression and apoptosis induced by cisplatin and cause redistribution of the cell cycle. Further assay indicates that modulation of Wnt/cadherin signaling pathway contributes to the chemosensitizing effect of Tetrandrine on the cytotoxicity of cisplatin in ovarian cancer. In vivo, the combination of Tetrandrine and cisplatin exhibits the strongest anti-cancer effect compared with each drug alone, with no obvious additional toxicity. These results provide rational evidence supporting the application of Tetrandrine as an adjunct to cisplatin in improvement of chemotherapy in ovarian cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI